Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation

Transplant Infectious Disease

Volumn 12, Issue 2, 2010, Pages 113-119

  Kim, S H ^a   Lee, S O ^a   Park, I A ^a   Park, S J ^a   Choi, S H ^a   Kim, Y S ^a   Woo, J H ^a   Park, S K ^a   Park, J S ^a   Kim, S C ^a   Han, D J ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Kidney transplantation; T SPOT.TB; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CELL ASSAY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INFECTION PREVENTION; INTERMETHOD COMPARISON; KIDNEY GRAFT; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN INDURATION; T LYMPHOCYTE; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; MICROSCOPY; NEUTROPHILS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TISSUE DONORS; TUBERCULIN TEST;

EID: 77950558968     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00495.x     Document Type: Article

References (22)

1. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998 27 : 1266 1277.
2. Aguado JM, Torre-Cisneros J, Fortun H, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009 48 : 1276 1284.
3. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004 4 (Suppl 10) : 160 163.
4. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005 40 : 581 587. (Pubitemid 40270229)
5. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004 4 : 761 766.
6. Kim SH, Song KH, Choi SJ, et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009 122 : 189 195.
7. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007 7 : 1 5.
8. Lindemann M, Dioury Y, Beckebaum S, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009 70 : 24 28.
9. World Health Organization. Available at http://apps.who.int/ globalatlas/dataQuery/(accessed September 21, 2009).
10. Ki HK, Son JS, Oh WS, et al. Infectious complications after liver transplantation according to donor: comparison between orthotopic and living donor transplantation. Infect Chemother 2004 36 : 139 148 (Korean).
11. Kim MS, Byun CG, Lee KY, et al. Mycobacterial infections after renal transplantation. J Korean Soc Transplant 1995 9 : 95 102 (Korean).
12. Passalent L, Khan K, Richardson RR, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007 2 : 68 73.
13. Hursitoglu M, Cikrikcioglu MA, Tukek T, et al. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients. Transpl Infect Dis 2009 11 : 28 32.
14. Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008 3 : 1357 1363.
15. Triverio PA, Bridevaux PO, Roux-Lombard P, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009 24 : 1952 1956.
16. Tanquay S, Killion JJ. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 1994 13 : 259 263.
17. Pai M, Zwerling A, Menzies D. Systemic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008 149 : 177 184.
18. Kim SH, Choi SJ, Kim HB, et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis. Arch Intern Med 2007 167 : 2255 2259.
19. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005 293 : 2756 2761.
20. Eleftheriadis T, Tsiaga P, Antoniadi G, et al. The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis 2005 46 : 706 712.
21. American Thoracic Society and Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 161 : S221 S247.
22. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008 3 : e2858.